Neurosteer Promotes Wearable Monitor to Detect Early Alzheimer’s

Neurosteer Promotes Wearable Monitor to Detect Early Alzheimer’s
Within a few years, doctors will be able to remotely evaluate patients for their risk of developing Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia — without having to hook them up to expensive, cumbersome machines generally found only in hospitals. That's the vision of Israeli entrepreneur Nathan Intrator, CEO of Neurosteer. “Millions of people suffer from neurodegenerative diseases, and as life expectancy goes up, that number will only increase,” Intrator told BioNews Services, publisher of this website. “There is no cure for these diseases, so our only hope at this point is to detect them quite early so patients can change lifestyle factors — diet, exercise, sleep and stress.” Intrator’s background is in mathematics, with an emphasis on signal processing. But his interest was always on the brain, and his doctoral thesis was on the theory of neuroplasticity. Intrator’s
Subscribe or to access all post and page content.